1Blagosklonny MV, Pardee AB. Exploiting cancer cell cycling for selective protection of nomal cells [J]. Cancer Res, 2001, 61 (11):4301-4305
2Hartwell L, Kastsan MB. Cell cycle control and cancer[J]. Science,1994, 266(4):1820-1828
3Doree M. Control of M-phase by maturation-promoting factor [J]. Curr Opin Cell Biol, 1990, 2(2):269-273
4Kao GD, Mckenna WG, Maity A, et al. Cyclin B1 availability is a rate-limiting component of the radiation induced G2 delay in Hela cells[J]. Oncogene, 1996, 13 (8):1647-1657
5Harper JW, Adamic GR, Wei N, et al. The p21 cdk-interacting protein Cip is a potent inhibitor of G1 cyclin-dependent kinase[J].Cell, 1993, 75(4):805-816
6Barboule N, Chadebech P, Baldin V, et al. Involvement of P21 in mitoticexit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell line[J]. Oncogene, 1997, 15(23):2867-2875
7Li FZ, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by Survivin[J]. Nature, 1998, 396(5):580-584
8Ambrosini G, Adida C, Sirugo G, et al. Inducing of apoptosis and inhibition of cell proliferation by survivin gene targeting [J]. J Biol Chem, 1998, 273(18):11177-11182
9ReedJC. The survivin saga goes in vivo [J].J Clin Invest, 2001,107(7):965-969
